Recap: Mednax Q2 Earnings

Shares of Mednax MD were flat in pre-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were down 64.04% over the past year to $0.32, which may not compare to the estimate of $0.09.

Revenue of $509,203,000 declined by 41.36% year over year, which missed the estimate of $555,920,000.

Outlook

Earnings guidance hasn't been issued by the company for now.

Mednax hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: Jul 30, 2020

Time: 10:00 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/4u5r53db

Technicals

52-week high: $28.66

Company's 52-week low was at $7.37

Price action over last quarter: Up 38.44%

Company Profile

Mednax provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment, which is physician services. Mednax generates roughly half of its revenue from the women's and children's services provided, and also roughly half of the company's total revenue is earned in the United States.